Researchers search the literature and vendor catalogs for antibodies
This can cost companies up to $3 million per year in wasted antibody spend
They then validate 5-12 commercial antibodies or order custom antibodies
The process takes weeks to months, yet still can't prevent downstream risk
Up to half of all commercially available antibodies are unreliable.
About 80% of life scientists use antibodies, spending $3 billion per year on more than 6 million products. But only half of commercially available antibodies are reliable1, and finding them is a challenge.
The technology collates relevant data, decodes it with AI, maps resulting knowledge with bioinformatic ontologies, and presents results in an intuitive interface.
Backed by Google’s AI fund, Gradient Ventures, and trusted by more than 31,000 scientists worldwide, BenchSci is the industry standard for antibody selection
Of scientists at 15 of the top 20 pharmaceutical companies that use BenchSci for AI-Assisted Antibody Selection2:
Report that BenchSci accelerates their work
Report purchasing fewer antibodies thanks to better antibody selection
Consider BenchSci an integral part of their workflow
See what customers, partners, and media say about BenchSci's impact